Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Maria Zannes, who has held the CEO position at the San Antonio-based biotechnology company since 2014, will see a bump in pay ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

The firm will use the proceeds to advance BE-101 for hemophilia B through clinical proof-of-concept testing and BE-102 for hypophosphatasia into the clinic.

Bayer AG (Leverkusen, Germany) announced a deal with Canada-based Smart Earth Camelina Corp., whereby Bayer has acquired ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that Chief Executive Officer Vlad Vitoc, M ...

High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globally Combined in-licensing and financing for a novel long-acting clinical ...

"It's very encouraging to see women's health highlighted so prominently as we kick off the new year; first with our joint ...

Market Growth: Understand the significant growth trajectory of the Contraceptive Implants segment, which is expected to reach US$9.8 Billion by 2030 with a CAGR of a 6.3%. The Spinal Implants segment ...

The new funding will support the commercial launch of the company's at-home screening test for colorectal cancer, as well as ...